| Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: a randomized controlled trial A Uster, U Ruefenacht, M Ruehlin, M Pless, M Siano, M Haefner, ... Nutrition 29 (11-12), 1342-1349, 2013 | 129 | 2013 |
| Functional genomics uncover the biology behind the responsiveness of head and neck squamous cell cancer patients to cetuximab P Bossi, C Bergamini, M Siano, M Cossu Rocca, AP Sponghini, F Favales, ... Clinical Cancer Research 22 (15), 3961-3970, 2016 | 74 | 2016 |
| Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients M Fässler, S Diem, J Mangana, O Hasan Ali, F Berner, D Bomze, S Ring, ... Journal for immunotherapy of cancer 7, 1-12, 2019 | 67 | 2019 |
| The point of pain in head and neck cancer P Bossi, R Giusti, A Tarsitano, M Airoldi, V De Sanctis, O Caspiani, ... Critical reviews in oncology/hematology 138, 51-59, 2019 | 65 | 2019 |
| The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma R Dummer, M Siano, RE Hunger, N Lindenblatt, R Braun, O Michielin, ... Swiss medical weekly 146, w14279, 2016 | 65 | 2016 |
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised … A Bottomley, C Coens, J Mierzynska, CU Blank, M Mandalà, GV Long, ... The lancet oncology 22 (5), 655-664, 2021 | 64 | 2021 |
| Pembrolizumab-triggered uveitis: an additional surrogate marker for responders in melanoma immunotherapy? S Diem, F Keller, R Rüesch, SA Maillard, DE Speiser, R Dummer, ... Journal of Immunotherapy 39 (9), 379-382, 2016 | 52 | 2016 |
| Anti-PD-1 therapy leads to near-complete remission in a patient with metastatic basal cell carcinoma S Fischer, OH Ali, W Jochum, T Kluckert, L Flatz, M Siano Oncology Research and Treatment 41 (6), 391-394, 2018 | 51 | 2018 |
| Lenvatinib in advanced radioiodine-refractory thyroid cancer-a retrospective analysis of the Swiss lenvatinib named patient program C Balmelli, N Railic, M Siano, K Feuerlein, R Cathomas, V Cristina, ... Journal of Cancer 9 (2), 250, 2018 | 49 | 2018 |
| Immunotherapies and future combination strategies for head and neck squamous cell carcinoma V Cristina, RG Herrera-Gómez, P Szturz, V Espeli, M Siano International journal of molecular sciences 20 (21), 5399, 2019 | 48 | 2019 |
| A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function M Siano, E Lerch, L Negretti, E Zucca, D Rodriguez-Abreu, M Oberson, ... Clinical Cancer Research 14 (23), 7935-7939, 2008 | 39 | 2008 |
| Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study JZ Drago, D Lawrence, E Livingstone, L Zimmer, T Chen, ... Melanoma research 29 (1), 65-69, 2019 | 36 | 2019 |
| Radiation dosimetry of 18F-AzaFol: A first in-human use of a folate receptor PET tracer S Gnesin, J Müller, IA Burger, A Meisel, M Siano, M Früh, M Choschzick, ... EJNMMI research 10, 1-12, 2020 | 34 | 2020 |
| Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinoma S Schmid, M Siano, M Joerger, R Rodriguez, J Müller, M Früh Lung Cancer 87 (1), 85-87, 2015 | 32 | 2015 |
| Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) J Feilchenfeldt, Z Varga, M Siano, HI Grabsch, U Held, B Schuknecht, ... British journal of cancer 113 (5), 716-721, 2015 | 30 | 2015 |
| Multicenter phase II study of panitumumab in platinum pretreated, advanced head and neck squamous cell cancer M Siano, F Molinari, V Martin, N Mach, M Früh, S Freguia, I Corradino, ... The oncologist 22 (7), 782-e70, 2017 | 27 | 2017 |
| Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08) M Früh, R Cathomas, M Siano, G Tscherry, A Zippelius, C Mamot, ... Clinical lung cancer 14 (1), 34-39, 2013 | 27 | 2013 |
| Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study. E Lengwiler, S Stampf, A Zippelius, E Salati, K Zaman, N Schäfer, ... Swiss medical weekly 149, w20078, 2019 | 24 | 2019 |
| Cost-effectiveness of nivolumab in the treatment of head and neck cancer A Hirschmann, JE Lupatsch, M Schwenkglenks, CM Panje, ... Oral oncology 87, 104-110, 2018 | 23 | 2018 |
| Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy M Siano, G Infante, C Resteghini, MC Cau, S Alfieri, C Bergamini, ... Oral oncology 69, 33-37, 2017 | 19 | 2017 |
